A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot--Marie--Tooth disease type 1

J Neurol Sci. 2001 Mar 1;184(2):149-53. doi: 10.1016/s0022-510x(00)00504-9.

Abstract

A novel mutation (Arg381Cys) in the second zinc-finger domain of early growth response 2 (EGR2) was identified in a late-onset Charcot--Marie--Tooth disease type 1 (CMT1) patient. This patient had initial symptoms of numbness and weakness in the leg at age 59, and a median nerve motor conduction velocity of 27 m/s. A sural nerve biopsy showed a severe loss of myelinated fibers with numerous onion bulbs. This is the first report of the EGR2 mutation presenting a late onset of CMT1 phenotype. Its mutation was a different amino acid substitution at codon 381 (Arg381His) which demonstrated congenital hypomyelinating neuropathy or early-onset CMT1. This report suggests that the EGR2 mutation represents divergent phenotypes at codon 381, which may be a mutation hotspot.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biopsy
  • Charcot-Marie-Tooth Disease / genetics*
  • DNA-Binding Proteins / genetics*
  • Early Growth Response Protein 2
  • Humans
  • Male
  • Mutation, Missense / genetics*
  • Phenotype
  • Sural Nerve / pathology
  • Transcription Factors / genetics*

Substances

  • DNA-Binding Proteins
  • EGR2 protein, human
  • Early Growth Response Protein 2
  • Transcription Factors